MentisCura

Curated by Signal

Diagnostics for central nervous system disorders

Overview

MentisCura develops and commercializes diagnostics for CNS disorders. Its platform technology combines EEG readings with fully automated algorithms to provide a differential diagnosis of neurodegenerative disorders. It has two products: Katla aimed at diagnosing attention deficit hyperactivity disorder (ADHD), and SIGLA to provide a differential diagnosis for dementia patients.

Key facts

Founded: 2004
Headquarters: Reykjavik, Iceland
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Nox Medical
Portable sleep and respiratory sleep monitoring systems
Health TechnologyReykjavik, Iceland
Monitor. InCardio
Mobile application to monitor heart rate
Health TechnologyIceland
Kara Connect
Teleconsultation marketplace connecting therapists and patients
Health TechnologyReykjavik, Iceland

About MentisCura

What does MentisCura do?

MentisCura develops and commercializes diagnostics for CNS disorders.

Where is MentisCura headquartered?

MentisCura is headquartered in Reykjavik, Iceland.

When was MentisCura founded?

MentisCura was founded in 2004.

Which sector is MentisCura in?

MentisCura operates in Health Technology.

Who are MentisCura's competitors?

Companies similar to MentisCura include Nox Medical, Monitor. InCardio, and Kara Connect.